Education
About Us
Working with TipRanks
Follow Us
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
Nektar Therapeutics (NKTR) Ownership Overview
1.09% Insiders
17.11% Mutual Funds
28.13% Other Institutional Investors
9.77% ETFs
43.90% Public Companies and
Individual Investors
The ownership structure of Nektar Therapeutics (NKTR) stock is a mix of institutional, retail, and individual investors. Approximately 55.00% of the company’s stock is owned by Institutional Investors, 1.09% is owned by Insiders, and 43.90% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 21, 2025 | xxxxxxxxxxxxx | $41826 | |
Aug 21, 2025 | xxxxxxxxxxxxx | $19278 | |
May 21, 2025 | xxxxxxxxxxxxx | $15549 | |
May 21, 2025 | xxxxxxxxxxxxx | $7177 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $746827 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $6360386 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $7744713 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,387,168 | Institution | 44.10% | 228,634,200 | |
| 6,650,000 | Institution | 34.97% | 181,279,000 | |
| 2,280,412 | Institution | 11.99% | 62,164,031 | |
| 1,064,103 | Insider | 5.60% | 29,007,448 | |
| 992,100 | Institution | 5.22% | 27,044,646 | |
| 555,295 | Institution | 2.92% | 15,137,342 | |
| 512,770 | Institution | 2.70% | 13,978,110 | |
| 314,296 | Insider | 1.65% | 8,567,709 | |
| 305,892 | Insider | 1.61% | 8,338,616 | |
| 299,718 | Institution | 1.58% | 8,170,313 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,387,168 | Institution | 44.10% | 228,634,200 | |
| 6,650,000 | Institution | 34.97% | 181,279,000 | |
| 2,280,412 | Institution | 11.99% | 62,164,031 | |
| 992,100 | Institution | 5.22% | 27,044,646 | |
| 512,770 | Institution | 2.70% | 13,978,110 | |
| 266,773 | Institution | 1.40% | 7,272,232 | |
| 261,128 | Institution | 1.37% | 7,118,349 | |
| 192,779 | Institution | 1.01% | 5,255,156 | |
| 151,005 | Institution | 0.79% | 4,116,396 | |
| 113,006 | Institution | 0.59% | 3,080,544 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 524,028 | Institution | 2.76% | 11,360,927 | |
| 120,867 | Institution | 0.64% | 2,620,397 | |
| 50,831 | Institution | 0.27% | 1,356,679 | |
| 50,802 | Institution | 0.27% | 1,384,863 | |
| 31,259 | Institution | 0.16% | 834,303 | |
| 28,083 | Institution | 0.15% | 765,543 | |
| 26,485 | Institution | 0.14% | 706,885 | |
| 8,354 | Institution | 0.04% | 222,968 | |
| 3,478 | Institution | 0.02% | 94,810 | |
| 507 | Institution | <0.01% | 353 |
FAQ
Who Owns Nektar Therapeutics (NKTR)?
According to the latest TipRanks data, approximately 28.13% of the company's stock is held by institutional investors, 1.09% is held by insiders, and 43.90% is held by retail investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 28.13% of Nektar Therapeutics (NKTR) stock is held by institutional investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by retail investors?
According to the latest TipRanks data, approximately 43.90% of Nektar Therapeutics (NKTR) stock is held by retail investors.
Who owns the most shares of Nektar Therapeutics (NKTR)?
VANGUARD INDEX FUNDS owns the most shares of Nektar Therapeutics (NKTR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.